Buy & Sell Enveric Biosciences Inc (ENVB) – Enveric Biosciences Inc Price Today
Key Stats
- $4.47MMarket Cap
- HealthSector
- -57.71%3M Drawdown
- -$210.04KEnterprise Value
- -Dividend Yield
- 91% Buy | 9% SellTrading Activity
- 3 daysTypical Hold Time
Enveric Biosciences Inc (ENVB) is currently valued at a market capitalization of $4.47M, with an enterprise value of -$210.04K. Over the past 52 weeks, Enveric Biosciences Inc has traded between a low of $1.79 and a high of $17.4, highlighting its annual price range. Over the past three months, Enveric Biosciences Inc has recorded a drawdown of -57.71%, reflecting recent price volatility. On average, investors hold Enveric Biosciences Inc for approximately 3 days, indicating typical investor behavior on the platform.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Most Recent News
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...
Regeneron's melanoma trial fails, stock drops over 10%, investors urged to explore legal options.
Regeneron Pharmaceuticals announced that its Phase 3 melanoma trial combining fianlimab and Libtayo did not meet the primary endpoint against Keytruda, causing the stock to fall more than 10%. Prior optimism from company executives about the trial's ...
